![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 211/58 | |
A61K 31/4468 | |||
A61P 25/00 | |||
A61P 7/02 |
(11) | Number of the document | 2289879 |
(13) | Kind of document | T |
(96) | European patent application number | 10180395.5 |
Date of filing the European patent application | 2005-09-26 | |
(97) | Date of publication of the European application | 2011-03-02 |
(45) | Date of publication and mention of the grant of the patent | 2014-11-12 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
614014 P | 2004-09-27 | US |
(72) |
Thygesen, Mikkel, DK
Schlienger, Nathalie, CH
Tolf, Bo-Ragnar, SE
Andersson, Carl-Magnus, SE
Blatter, Fritz, CH
Berghausen, Jörg, DE
|
(73) |
Acadia Pharmaceuticals Inc.,
11085 Torreyana Road, Ste. 100, San-Diego, CA 92121-1104,
US
|
(54) | Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n`-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |
Synthesis of a crystalline form of n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n`-(4-(2-methylpropyloxy)phenylmethyl)carbamide tartrate salt |